DC-HIL in cancer
- Institution
- VA NORTH TEXAS HEALTH CARE SYSTEM, TX
- Principal investigator
- Ponciano D Cruz
- Funding
- —
- Duration
- 2018–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Melanoma is a significant cause of morbidity and mortality in the U.S. and among military veterans. Having discovered an immune-vascular regulating pathway (DC- HIL/SD4) whose function can be manipulated to treat cancers, we will: (1) dissect its effects on immunity and vascularity in melanoma; (2) develop treatment targeted at a key carbohydrate component of the pathway; and (3) characterize changes in this component during melanoma growth and metastasis. Our results will improve current management of metastatic melanoma and potentially other cancers.
LOADING MOONBASE SCORE
Questions for VA NORTH TEXAS HEALTH CARE SYSTEM
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · VA North Texas Health Care SystemNot yet scored
Role of MIF-CD74 signaling as an immune regulator and therapy target in pancreas cancer.
Ravikanth Maddipati · 2025–2029
- NIH · VA North Texas Health Care SystemNot yet scored
Veteran Employment and Economic Security Research Consortium
James Lepage · 2024–2029
- NIH · VA North Texas Health Care SystemNot yet scored
MOTIVATE to Improve Outcomes for Older Veterans with Musculoskeletal Pain and Depression
Una E. Makris · 2022–2026